Identification of three novel genetic variants in the melanocortin-3 receptor of obese children

Obesity

Volumn 19, Issue 1, 2011, Pages 152-159

  Zegers, Doreen ^a   Beckers, Sigri ^a   De Freitas, Fenna ^a   Peeters, Armand V ^a   Mertens, Ilse L ^b   Verhulst, Stijn L ^b   Rooman, Raoul P ^b   Timmermans, Jean Pierre ^a   Desager, Kristine N ^b   Massa, Guy ^c   Van Gaal, Luc F ^b   Van Hul, Wim ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c VIRGA JESSE HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LEPTIN; MELANOCORTIN; MELANOCORTIN 3 RECEPTOR;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FUNCTIONAL DISEASE; GENE; GENE MUTATION; GENETIC CODE; GENETIC IDENTIFICATION; GENETIC VARIABILITY; GENETICS; HETEROZYGOSITY; HUMAN; HYPOTHALAMUS; I2261 GENE; L95L GENE; MAJOR CLINICAL STUDY; MALE; MC3R GENE; MIDDLE AGED; MORBID OBESITY; MUTATION; NUCLEOTIDE SEQUENCE; OBESITY; PATHOGENESIS; PHYSIOLOGY; S69S GENE; SCHOOL CHILD;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; BASE SEQUENCE; CHILD; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; MUTATION; OBESITY; OBESITY, MORBID; RECEPTOR, MELANOCORTIN, TYPE 3;

EID: 78650679801     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.127     Document Type: Article

References (38)

1. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell 2001;104:531-543.
2. Elmquist JK. Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin. Physiol Behav 2001;74:703-708.
3. Abbott CR, Kennedy AR, Wren AM et al. Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormone. Endocrinology 2003;144:3943-3949.
4. Gantz I, Konda Y, Tashiro T et al. Molecular cloning of a novel melanocortin receptor. J Biol Chem 1993;268:8246-8250.
5. Roselli-Rehfuss L, Mountjoy KG, Robbins LS et al. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 1993;90:8856-8860.
6. Gantz I, Miwa H, Konda Y et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 1993;268: 15174-15179.
7. Butler AA, Kesterson RA, Khong K et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000;141:3518-3521.
8. Chen AS, Marsh DJ, Trumbauer ME et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 2000;26:97-102.
9. Pritchard LE, Turnbull AV, White A. Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J Endocrinol 2002;172:411-421.
10. Zhang Y, Kilroy GE, Henagan TM et al. Targeted deletion of melanocortin receptor subtypes 3 and 4, but not CART, alters nutrient partitioning and compromises behavioral and metabolic responses to leptin. FASEB J 2005;19:1482-1491.
11. Lee M, Kim A, Conwell IM et al. Effects of selective modulation of the central melanocortin-3-receptor on food intake and hypothalamic POMC expression. Peptides 2008;29:440-447.
12. Li WD, Joo EJ, Furlong EB et al. Melanocortin 3 receptor (MC3R) gene variants in extremely obese women. Int J Obes Relat Metab Disord 2000;24:206-210.
13. Hani EH, Dupont S, Durand E et al. Naturally occurring mutations in the melanocortin receptor 3 gene are not associated with type 2 diabetes mellitus in French Caucasians. J Clin Endocrinol Metab 2001;86: 2895-2898.
14. Boucher N, Lanouette CM, Larose M et al. A +2138InsCAGACC polymorphism of the melanocortin receptor 3 gene is associated in human with fat level and partitioning in interaction with body corpulence. Mol Med 2002;8:158-165.
15. Calton MA, Ersoy BA, Zhang S et al. Association of functionally significant Melanocortin-4 but not Melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study. Hum Mol Genet 2009;18:1140-1147.
16. Lee YS, Poh LK, Loke KY. A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. J Clin Endocrinol Metab 2002;87:1423-1426.
17. Tao YX, Segaloff DL. Functional characterization of melanocortin-3 receptor variants identify a loss-of-function mutation involving an amino acid critical for G protein-coupled receptor activation. J Clin Endocrinol Metab 2004;89:3936-3942.
18. Rached M, Buronfosse A, Begeot M, Penhoat A. Inactivation and intracellular retention of the human I183N mutated melanocortin 3 receptor associated with obesity. Biochim Biophys Acta 2004;1689:229-234.
19. Tao YX. Functional characterization of novel melanocortin-3 receptor mutations identified from obese subjects. Biochim Biophys Acta 2007;1772:1167-1174.
20. Lee YS, Poh LK, Kek BL, Loke KY. The role of melanocortin 3 receptor gene in childhood obesity. Diabetes 2007;56:2622-2630.
21. Mencarelli M, Walker GE, Maestrini S et al. Sporadic mutations in melanocortin receptor 3 in morbid obese individuals. Eur J Hum Genet 2008;16:581-586.
22. Roelants M, Hauspie R, Hoppenbrouwers K. References for growth and pubertal development from birth to 21 years in Flanders, Belgium. Ann Hum Biol 2009;36:680-694.
23. Miller SA, Dykes DD, Polesky H F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
24. Wittwer CT, Reed GH, Gundry CN, Vandersteen JG, Pryor RJ. High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem 2003;49:853-860.
25. Zhou L, Wang L, Palais R, Pryor R, Wittwer CT. High-resolution DNA melting analysis for simultaneous mutation scanning and genotyping in solution. Clin Chem 2005;51:1770-1777.
26. Rached M, Buronfosse A, Durand P, Begeot M, Penhoat A. Stable expression of human melanocortin 3 receptor fused to EGFP in the HEK293 cells. Biochem Biophys Res Commun 2003;306:208-212.
27. Wright CS. Structural comparison of the two distinct sugar binding sites in wheat germ agglutinin isolectin II. J Mol Biol 1984;178:91-104.
28. Farooqi IS, Keogh JM, Yeo GS et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003;348:1085-1095.
29. Tao YX. Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Mol Cell Endocrinol 2005; 239:1-14.
30. Wong J, Love DR, Kyle C et al. Melanocortin-3 receptor gene variants in a Maori kindred with obesity and early onset type 2 diabetes. Diabetes Res Clin Pract 2002;58:61-71.
31. GPCR. GPCRDB: Information system for G protein-coupled receptors (GPCRs). http://www.gpcr.org/7tm/ (2006). Accessed 26 January 2009.
32. Yeo GS, Lank EJ, Farooqi IS et al. Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms. Hum Mol Genet 2003;12:561-574.
33. Chai B, Li JY, Zhang W, Ammori JB, Mulholland MW. Melanocortin-3 receptor activates MAP kinase via PI3 kinase. Regul Pept 2007;139: 115-121.
34. Pogozheva ID, Chai BX, Lomize AL et al. Interactions of human melanocortin 4 receptor with nonpeptide and peptide agonists. Biochemistry 2005;44:11329-11341.
35. Oosterom J, Nijenhuis WA, Schaaper WM et al. Conformation of the core sequence in melanocortin peptides directs selectivity for the melanocortin MC3 and MC4 receptors. J Biol Chem 1999;274:16853-16860.
36. Schiöth HB, Muceniece R, Szardenings M et al. Characterisation of D117A and H260A mutations in the melanocortin 1 receptor. Mol Cell Endocrinol 1997;126:213-219.
37. Schiöth HB, Yook P, Muceniece R, Wikberg JE, Szardenings M. Chimeric melanocortin MC1 and MC3 receptors: identification of domains participating in binding of melanocyte-stimulating hormone peptides. Mol Pharmacol 1998;54:154-161.
38. Ellgaard L, Helenius A. Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 2003;4:181-191.